The Oncology Institute Reports First Quarter 2026 Financial Results
Go back to The Oncology Institute Reports First Quarter 2026 Financial Results| TARGETS Trust XXIV 7% TARGETS with respect to the common stock of Intel Corporation (NASDAQ: TOI) | Delayed: 5.08 +0.07 (1.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.01 | 52 Week High | $7.47 | |||
| Open | $4.90 | 52 Week Low | $7.47 | |||
| Day High | $5.19 | P/E | N/A | |||
| Day Low | $4.90 | EPS | $0.00 | |||
| Volume | 269,399 | |||||
| TARGETS Trust XXIV 7% TARGETS with respect to the common stock of Intel Corporation (NASDAQ: TOI) | Delayed: 5.08 +0.07 (1.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.01 | 52 Week High | $7.47 | |||
| Open | $4.90 | 52 Week Low | $7.47 | |||
| Day High | $5.19 | P/E | N/A | |||
| Day Low | $4.90 | EPS | $0.00 | |||
| Volume | 269,399 | |||||
